Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $1B+, returning 12,400%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 12,400% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Abivax SA American Depositary Shares (ABVX) | 1,432.87% |
Diginex Limited Ordinary Shares (DGNX) | 1,139.44% |
Palvella Therapeutics (PVLA) | 733.85% |
Cidara Therapeutics (CDTX) | 711.69% |
Terns Pharmaceuticals (TERN) | 660.99% |
Celcuity LLC (CELC) | 659.38% |
Newegg Commerce (NEGG) | 635.75% |
Nanobiotix (NBTX) | 617.68% |
TMC the metals (TMC) | 503.51% |
Sandisk (SNDK) | 497.01% |
Americas Silver (USAS) | 486.32% |
Hycroft Mining (HYMC) | 485.4% |
Olema Pharmaceuticals (OLMA) | 479.05% |
Almonty Industries Inc Common Shares (ALM) | 454.17% |
Nutex Health (NUTX) | 436.12% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 432.51% |
Cogent Biosciences (COGT) | 406.2% |
GRAIL, LLC (GRAL) | 388.33% |
Resolute Holdings Management (RHLD) | 362.85% |
EchoStar (SATS) | 347.88% |
Anywhere Real Estate (HOUS) | 339.58% |
Planet Labs PBC (PL) | 337.16% |
Aris Mining (ARMN) | 336.34% |
